Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Claudia Jenneck"'
Publikováno v:
Pädiatrie. 22:S26-S34
Die Diagnose des atopischen Ekzems ist nicht in allen Fallen leicht zu stellen. Die Kenntnis verschiedener Differenzialdiagnosen spielt dabei eine grose Rolle. Neben den Differenzialdiagnosen werden im folgenden Beitrag auch Erkrankungen vorgestellt,
Publikováno v:
Annals of Allergy, Asthma & Immunology. 99:13-21
Objectives To provide an overview of aspirin intolerance (AI), to summarize the latest genetic and pathophysiologic findings, and to discuss the current therapeutic recommendations, including aspirin desensitization. Data Sources Using the PubMed dat
Publikováno v:
Der Hautarzt. 58:163-176
Das atopische Ekzem (AE) ist eine haufige chronisch rezidivierende entzundliche Hauterkrankung, an der etwa 10–20% der Kinder und 1–3% der Erwachsenen erkranken. Die Diagnose des AE wird klinisch beispielsweise anhand der Kriterien von Hanifin un
Autor:
Elke Rodriguez, Claudia Jenneck, Markus M. Nöthen, Colin N. A. Palmer, Natalija Novak, Laura Maintz, Johannes Ring, Stefan Wagenpfeil, Tobias Hagemann, Stephan Weidinger, W.H. Irwin McLean, Heidrun Behrendt, Norman Klopp, Yiwei Zhao, Simon P. Lee, Hansjörg Baurecht, Thomas Illig, Haihui Liao, Alan D. Irvine, Amalia Diaz-Lacava
Publikováno v:
J. Allergy Clin. Immunol. 118, 214-219 (2006)
BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease with a strong genetic background. One of the characteristic features of AD and causative factor for the disease is an impaired epidermal skin barrier based on a primary defect
Autor:
Thomas Bieber, Tobias Hagemann, Natalija Novak, Rudolf Valenta, Bodo Niggemann, Stephan Weidinger, Claudia Jenneck, Nadine Mothes
Publikováno v:
Journal of Allergy and Clinical Immunology. 116:706-709
Autor:
Jean-Pierre Allam, Thomas Bieber, Tobias Hagemann, Jarema Peter Kochan, Natalija Novak, Rudolf Valenta, Sylvia Laffer, Claudia Jenneck
Publikováno v:
Journal of Allergy and Clinical Immunology. 114:364-370
Background The high-affinity receptor for IgE (FceRI) on myeloid dendritic cells has been shown to play a major role in atopic dermatitis (AD). Plasmacytoid dendritic cells (pDCs), which are instrumental in the defense of viral infections, are presen
Autor:
Claudia, Jenneck, Natalija, Novak
Publikováno v:
Therapeutics and Clinical Risk Management
Alefacept is the first biological agent approved by the US Food and Drug Administration (FDA) for the treatment of moderate to severe chronic plaque psoriasis. It is a full human fusion protein binding to CD2 on T cells. With its dual mechanism of ac
Autor:
Laura Maintz, Rolf Fimmers, Thomas Bieber, Natalija Novak, Claudia Jenneck, Susanne Kruse, Stephan Weidinger, Jana Potreck
Publikováno v:
The Journal of allergy and clinical immunology. 115(4)
Background Human IL-18 is an inflammatory cytokine that plays a role in atopic diseases, such as atopic eczema (AE), by enhancing IL-4 and IL-13 production and stimulating the synthesis of IgE. Objective To evaluate associations of polymorphisms in t